The drug inspection and testing system constitutes an important part of the drug regulatory system. Per the relevant requirements of the Thirteenth Five-Year Plan for National Drug Safety and the Construction Standards for Drug Inspection and Testing Centers (Institutions and Institutes) (Construction Standard 187- 2017), to strengthen the guidance over drug inspection and testing institutions in capacity building and improve their corresponding capabilities, NMPA has organized the formulation of and released on August 30, 2019 the Guiding Principles for Capacity Building of Drug Inspection and Testing Institutions.